Gynecology & Obstetrics in Maryland

InVitroCare is a specialized manufacturer of assisted reproductive technology (ART) media and reagents for fertility clinics and IVF laboratories. The company provides a comprehensive range of products including IUI (intrauterine insemination) systems, sperm isolation and preparation products, embryo culture media, ICSI (intracytoplasmic sperm injection) reagents, and sperm freezing media. All products are pre-measured, ready-to-use formulations designed for clinical efficiency. InVitroCare manufactures in FDA-registered facilities compliant with QMS, GAMP®5, and ISO 13485 standards, serving reproductive medicine practices and fertility centers with high-quality, regulated consumables for gamete and embryo handling.

Ambu A/S is the global market leader in single-use endoscopy, a category the company created in 2009. The company manufactures and distributes a comprehensive portfolio of single-use (disposable) endoscopic devices and airway management solutions for hospitals, emergency care settings, and training environments. Core product lines include the aScope™ family of flexible endoscopes for pulmonology (bronchoscopy), gastroenterology (gastroscopy), urology (cystoscopy), and ENT applications, as well as rigid and semi-rigid visualization systems. Specialty products include the aScope™ 5 Broncho with color-coded sizing, aScope™ Gastro Large for therapeutic gastroscopy, aScope™ 5 Cysto HD for urology with superior image quality, and the aScope™ 4 Broncho Sampler Set for improved BAL/BW workflow. The company also offers airway management solutions, including the SureSight™ Connect video laryngoscope for intubation and upper airway visualization. Ambu serves multiple clinical specialties: pulmonology, ENT, gastroenterology, urology, neurology, cardiology, and anesthesia. The company has received recognition for technology innovation, earning the 2025 Frost & Sullivan Technology Innovation Leadership Recognition in the European single-use endoscopy industry. All products are single-use, sterile, and designed to eliminate cross-contamination risks associated with reusable instruments. Ambu operates globally with local representatives and maintains both hospital and emergency/training market segments.

Xcision Medical Systems develops the GammaPod, the first and only FDA-cleared stereotactic radiotherapy system specifically designed for early-stage breast cancer treatment. The company focuses exclusively on advancing breast cancer care through innovative radiation oncology technology. The GammaPod platform enables significantly shortened treatment courses (5 days or fewer) compared to conventional external beam radiation therapy (4–6 weeks), delivering non-invasive, non-surgical treatment with rapid recovery. The system uses advanced imaging and radiation delivery to provide patient-friendly, protective care for eligible early-stage breast cancer patients. Xcision is headquartered in Columbia, Maryland, and actively participates in major oncology conferences (ESTRO, Arab Health) and industry initiatives to modernize radiation oncology reimbursement. The company holds FDA clearance for the GammaPod and is engaged in clinical and commercial partnerships to expand access to this specialized breast cancer treatment modality.

InnoVital LLC is a Beltsville, Maryland-based advanced technology company with dual operating divisions: InnoVital Defense and InnoVital Health. The company develops innovative medical device solutions and specialized equipment addressing critical clinical and emergency care needs. InnoVital's multidisciplinary team of physicians, engineers, and entrepreneurs designs and manufactures novel medical devices including surgical airway guidance systems, pleural access anatomical guides, rapid casualty extraction and patient transport systems, catheter-based suction-irrigation devices, and respiratory therapy accessories. The company leverages core competencies in advanced electronics, sensors, actuation, signal processing, and control systems to create purpose-built solutions for emergency medicine, surgical interventions, and home respiratory care. InnoVital maintains strong relationships with the US Defense Health Agency and clinical institutions, with active clinical trials and continued government funding supporting product development and commercialization.

Trinity Sterile, Inc. is a certified Minority Business Enterprise (MBE) founded in 2004 and based in Salisbury, Maryland, specializing in the manufacture and assembly of sterile medical kits, procedure trays, and disposable/reusable medical supplies for the healthcare industry. The company operates with approximately 110 employees and reported revenue of $27.6 million, establishing itself as one of the fastest-growing MBEs. Trinity Sterile manufactures surgical instruments, phlebotomy tourniquets, IV start kits, incontinence care products, and the Esmark Sterile Bandage line for wound care applications. The facility employs ethylene oxide (EtO) sterilization to ensure high safety and quality standards. The company offers custom medical kit solutions designed to streamline healthcare workflows, reduce operational costs, and enhance care delivery across diverse healthcare settings ranging from large hospital systems to specialized clinics. Trinity Sterile is ISO 13485:2016 certified and brings over 70 years of certified quality experience to its product offerings.

CoapTech manufactures the PUMA-G System, the FDA-cleared ultrasound-guided percutaneous gastrostomy (PUG) solution for bedside feeding tube placement in critical care and acute care settings. The system enables physicians and advanced practice providers to perform gastrostomy procedures at the patient bedside using ultrasound visualization, eliminating the need for operating room scheduling, endoscopic reprocessing, or fluoroscopy exposure. Clinical evidence demonstrates significant hospital cost reductions (up to $34,778 per patient) and shortened ICU length of stay (5–10 days) compared to traditional PEG or PRG procedures. The PUMA-G System is deployed in ICUs, step-down units, floor units, interventional radiology suites, and long-term acute care hospitals. The system reduces procedural risks including organ perforation from blind sticks, infection from endoscope reprocessing, and radiation exposure from fluoroscopy. Key clinical applications include COVID-19 patient care (tandem tracheostomy–gastrostomy procedures) and integration into critical care teams to optimize patient throughput and procedural efficiency. CoapTech holds FDA 510(k) clearance and serves tertiary care centers, academic medical centers, community hospitals, and for-profit hospital systems across the United States.

Medispec is a pioneer and leading global manufacturer of non-invasive extracorporeal shockwave therapy (ESWT) devices serving 80 countries. Founded 30+ years ago by medical professionals and engineers, Medispec specializes in low-intensity shockwave therapy for regenerative treatment across multiple medical disciplines. The company's flagship products address erectile dysfunction (ED1000), female sexual dysfunction (LilyCare), kidney stone lithotripsy (EM1000), and orthopedic conditions (Orthospec). All devices utilize patented multi-wave shockwave technology with unique reflector design for targeted treatment delivery. Medispec's therapies are non-surgical, clinically validated, and designed for supervised outpatient sessions. The company serves doctors, urology clinics, sexual health practices, and orthopedic facilities worldwide, with particular strength in urology, gynecology, and sexual health treatment modalities.